首页> 美国卫生研究院文献>Journal of Clinical Laboratory Analysis >Feasibility of CYFRA 21‐1 as a serum biomarker for the detection of colorectal adenoma and advanced colorectal adenoma in people over the age of 45
【2h】

Feasibility of CYFRA 21‐1 as a serum biomarker for the detection of colorectal adenoma and advanced colorectal adenoma in people over the age of 45

机译:CYFRA 21-1作为血清生物标志物检测45岁以上人群大肠腺瘤和晚期大肠腺瘤的可行性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Colon adenoma ( ) is a premalignant lesion of colorectal cancer, and its early removal is closely associated with more prolonged survival in the general population. In this study, we aimed to evaluate the relationship between diverse biologic markers and a newly diagnosed and to predict the clinical possibility of cytokeratin‐19 soluble in serum fragment ( 21‐1) as a screening tool in asymptomatic adults aged over 45 years.
机译:结肠腺瘤()是大肠癌的恶变前病变,其早期切除与普通人群中更长的生存期密切相关。在这项研究中,我们旨在评估各种生物学标志物与新诊断的疾病之间的关系,并预测可溶于血清片段(21-1)中的细胞角蛋白19作为45岁以上无症状成年人的筛查工具的临床可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号